Description

BUDESHINE F 400 is a combination inhalation therapy containing Formoterol Fumarate, a long-acting β2-agonist (LABA), and Budesonide, an inhaled corticosteroid (ICS). This dual-action formulation is designed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), providing both bronchodilation and anti-inflammatory effects. Administered as a dry powder inhaler (DPI), BUDESHINE F 400 offers rapid relief from bronchospasm while also suppressing airway inflammation, thereby reducing the frequency and severity of symptoms such as wheezing, coughing, chest tightness, and breathlessness. Mechanism of Action: ✅ Formoterol Fumarate (6 mcg): A long-acting β2-adrenergic agonist (LABA). Stimulates β2 receptors in bronchial smooth muscle, resulting in bronchodilation. Fast onset of action (within minutes) and a prolonged effect (up to 12 hours). Reduces airway resistance and improves airflow. ✅ Budesonide (400 mcg): A potent inhaled corticosteroid (ICS). Reduces inflammation, edema, and mucus secretion in the airways. Helps prevent asthma exacerbations and COPD flare-ups with regular use. Acts locally in the lungs with minimal systemic absorption, lowering the risk of systemic side effects. Together, these two drugs provide synergistic benefits by addressing both the bronchoconstrictive and inflammatory components of asthma and COPD. Indications: BUDESHINE F 400 is indicated for: Maintenance treatment of asthma in patients aged 12 years and older who require both inhaled corticosteroids and long-acting β2-agonists. Chronic Obstructive Pulmonary Disease (COPD): Long-term maintenance therapy to reduce symptoms and exacerbations. Prevention of nocturnal asthma symptoms and exercise-induced bronchospasm (as part of a regular maintenance regimen). Not intended for acute relief of bronchospasm (rescue inhalers like salbutamol/albuterol should be used for emergencies). Key Benefits: ✅ Dual-action relief – anti-inflammatory + bronchodilation ✅ Rapid onset of action – Formoterol provides quick symptom relief ✅ Convenient once or twice-daily dosing ✅ Reduces need for rescue medication ✅ Improves lung function and quality of life ✅ Minimizes the risk of asthma and COPD exacerbations Dosage and Administration: Recommended Dosage (Adults and Adolescents ≥12 years): Asthma (Maintenance Therapy): 1 inhalation twice daily (morning and evening) COPD: 1 inhalation twice daily Maximum Dose: Up to 2 inhalations twice daily, depending on the severity and as prescribed by a physician. The exact dose and duration should always be determined by a healthcare professional based on the patient’s response and severity of the disease. Usage Instructions: Use only with a compatible Rotahaler or DPI device. Do not swallow the capsule. Place the capsule in the inhalation device and inhale the powder deeply through the mouth. Rinse mouth with water after each use to prevent oral thrush (candidiasis). Do not exhale into the device. Conclusion: BUDESHINE F 400 delivers powerful dual therapy for asthma and COPD by combining a rapid-acting bronchodilator (Formoterol) with a potent anti-inflammatory corticosteroid (Budesonide). This combination not only improves lung function but also reduces the frequency of exacerbations and enhances overall respiratory health. Ideal for long-term management, BUDESHINE F 400 helps patients breathe easier, live more actively, and reduce dependency on rescue medications — all with the convenience of a single inhaler.